Our finances and how we spend your donations

 

The DHT receives the majority of its income from donations from individuals and gifts in wills. We also receive funding from other charitable trusts and foundations and an income from ethical investments.

Our income varies year on year and a summary of our income and spending for the most recent financial year can be seen below.

 

Income 

2014/2015*

2015/2016

Donations

£         399,876

£        332,143

Legacies

£         859,658

£        415,563

Other income

£             9,734

£          75,061

Total

£      1,269,268

£        822,767

 

   

Expenditure 

2014/2015*

2015/2016

Charitable activities

£       1,294,134

£      1,050,577

Trading activities

£              6,184

£         100,282

Total

£      1,300,318

£      1,150,859

 

*Refers to the consolidated accounts of the Dr Hadwen Trust for Humane research (reg. charity number 261096) and the Dr Hadwen Trust (reg. charity number 1146896).

Our spending on non-animal research in 2015/2016

From 1st April 2015 - 31st March 2016 the Dr Hadwen Trust distributed £571,354 to research projects that took place or began during the year. Of the £571,354, the sum of £528,752 (2015: £706,600) was attributed to 17 (2015: 19) ongoing research projects awarded prior to 2015. These included advanced chronic kidney disease, brain tumour research, brain imaging techniques, pre-clinical drug screening, schizophrenia, pain and diabetes research. During the year, the trustees of the Dr Hadwen Trust awarded further grant funding of £154,033 to two new three-year diabetes (University of Exeter) and pain (Belfast University) PhD research projects.

Awarding strategic grants

In order to further develop research previously funded by the Dr Hadwen Trust, trustees awarded £311,409 to a five year strategic grant researching medical devices using Thiel embalmed cadavers at the University of Dundee. The grant funding will expand the original project which looked at how Thiel cadavers could offer an alternative to animal testing in the preliminary phases of development, testing and training of medical devices (such as cardiovascular stents).
The five year project will include the development of training opportunities which will allow incorporation of the Thiel model as an alternative to animal use in locally delivered courses in Dundee for cardiovascular, respiratory and urological interventions. In addition it will allow collaboration with industry to test cardiovascular and respiratory devices and to establish the use of the Thiel cadaver models as a viable animal alternative.
The project will also include various stakeholder engagement elements which will allow local and national dissemination of the Thiel model advantages in cardiovascular, respiratory, liver and kidney medical device training and testing.

Animal Replacement Centre of Excellence

The Dr Hadwen Trust has been in negotiations with Queen Mary University of London to establish the world’s first Animal Replacement Centre of Excellence (The ARC) which will be based at the university. To secure the funding for the centre, we have made a five year commitment to Queen Mary University of London, including an in-year designation of £601.560.  Of this funding, £491,560 is from an endowed legacy donation from Alan Stross bequeathed to the linked charity the Dr Hadwen Trust for Humane Research.  The bequest was released by the Charity Commission in 2016, and £50,000 resides in restricted funds intended to support the Alan and Kathie Stross Summer Fellowships in perpetuity.

Early Career Scientists

During the year we continued to recognise the importance of embedding the value of using animal replacement technologies into the minds of the next generation of biomedical research scientists.  We increased the funding allocated to our Summer Studentship scheme to £25,475 (2015: £12,400), and supported 14 students to complete summer research projects (2015:7).  This initiative acknowledges the importance of supporting and educating the next generation of research scientists and advocates the role these research scientists of tomorrow have in embedding the use of animal replacement technologies. The 14 summer studentship research projects took place at universities across the UK, covering a diverse range of projects.  

Full details of the DHT's current financial position can be found in our latest annual report, and details of our past income and spending are freely available via the Charity Commission website.  As the DHT became incorporated as a charitable company in 2013, accounts for years prior to 2014 can be found by searching for charity number 261096.

Our investment policy

• The DHT seeks to achieve maximum return from investments whilst ensuring that the financial and ethical requirements of the DHT are met.

• The Investment Policy takes into account the guidance of the Charity Commission on ethical and socially responsible investment of charity funds as well as the DHT's mission and values.

• The trustees of the DHT will review and publish the Investment Policy annually, to ensure that it remains fit for purpose.

If you would like to view our full investment policy, please email info@drhadwentrust.org.

Quick links